Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04925154 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tradeoffs in Patient Decision Making About Rectal Cancer Treatment: Benefits Compared to Quality Of Life.

Study acronym: Pathos
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 1, 2025 to Dec 1, 2027
    • Study completion date: Jan 1, 2026 to Jan 1, 2028
    v9
  2. Primary completion date: Dec 1, 2023 to Dec 1, 2025
    • Study completion date: Jan 1, 2024 to Jan 1, 2026
    v8
  3. Enrollment target: 28 to 192
    • Study description revised
    v7
  4. Primary completion date: May 1, 2022 to Dec 1, 2023
    • Study completion date: Jun 1, 2022 to Jan 1, 2024
    v6
  5. Trial status: Not Yet Recruiting to Recruitingv5 Show 6 more changesShow less
    • Enrollment target: 58 to 28
    • Study sites: 0 to 1
    • Primary completion date: Feb 1, 2022 to May 1, 2022
    • Study completion date: Apr 1, 2022 to Jun 1, 2022
    • Start date changed from estimate of Dec 1, 2021 to Dec 13, 2021
    • Study description revised
Show 3 earlier versionsHide 3 earlier versions
  1. Start date: Oct 1, 2021 to Dec 1, 2021
    • Primary completion date: Nov 1, 2021 to Feb 1, 2022
    • Study completion date: Dec 1, 2021 to Apr 1, 2022
    v4
  2. Start date: Jul 1, 2021 to Oct 1, 2021
    • Primary completion date: Sep 1, 2021 to Nov 1, 2021
    • Study completion date: Oct 1, 2021 to Dec 1, 2021
    v3
  3. Secondary endpoints: details revised at 1 of 1 entry
    • Study description shortened, about 1 word
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is aiming to look into patients' treatment preferences and their socio economic background as well as the exploration of thought processes leading to these preferences. It will integrate, in two exploratory questionnaires, the three most common treatment schema (standard of care, non-operative management, surgery alone) all of which have been demonstrated efficacious.
Trial Details
NCT Number NCT04925154
Lead Sponsor Sir Mortimer B. Davis - Jewish General Hospital
Conditions
(from sponsor)		 Patient Preference
Related terms Colorectal Neoplasms, Patient Preference
Enrollment 192 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov